Furthermore, HSP90 has been implicated in hematological malignancies, including acute myeloid leukemia [36], mantle cell lymphoma [37], acute lymphoblastic leukemia [38], T-cell leukemia [39], and chronic lymphocytic leukemia [40]. This evidence concerns the gene HSP90AB1 and T-cell leukemia.